Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 328-38-1
2. H-d-leu-oh
3. (2r)-2-amino-4-methylpentanoic Acid
4. (r)-leucine
5. Leucine, D-
6. (r)-(-)-leucine
7. (r)-2-amino-4-methylpentanoic Acid
8. D-homo-valine
9. D-2-amino-4-methylvaleric Acid
10. D-leu
11. D-leucin
12. D-leuzin
13. Chebi:28225
14. (2r)-2-azaniumyl-4-methylpentanoate
15. 965cod96ya
16. Ncgc00163335-01
17. Dsstox_cid_26347
18. Dsstox_rid_81551
19. Dsstox_gsid_46347
20. Dle
21. Leucine,d
22. Mfcd00063088
23. Cas-328-38-1
24. Unii-965cod96ya
25. Nsc-77687
26. D-2-amino-4-methylpentanoic Acid
27. (d)-leucine
28. Einecs 206-327-7
29. Nsc 77687
30. D-leu42
31. Ai3-52422
32. Schembl42012
33. D-leucineleucine, D-
34. Chembl1232258
35. Dtxsid6046347
36. Zinc388396
37. (r)-2-amino-4-methylvaleric Acid
38. Act04820
39. Bcp30475
40. Cs-d1369
41. D-leucine, Reagentplus(r), 99%
42. Hy-y0378
43. Tox21_112049
44. Bdbm50463213
45. (r)-2-amino-4-methyl-pentanoic Acid
46. Akos015841823
47. Tox21_112049_1
48. Ac-8658
49. Am81870
50. Db01746
51. (2r)-2-amino-4-methyl-pentanoic Acid
52. Ncgc00013565-03
53. Ncgc00163335-02
54. Ncgc00163335-03
55. As-12286
56. D-leucine, Vetec(tm) Reagent Grade, 97%
57. (r)-4-methyl-2-aminopentanoic Acid
58. L0027
59. C01570
60. Q16081973
61. F1905-7150
62. Z966690616
63. D-2-amino-4-methylpentanoic Acid;(r)-leucine;h-d-leu-oh
| Molecular Weight | 131.17 g/mol |
|---|---|
| Molecular Formula | C6H13NO2 |
| XLogP3 | -1.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 3 |
| Exact Mass | 131.094628657 g/mol |
| Monoisotopic Mass | 131.094628657 g/mol |
| Topological Polar Surface Area | 63.3 Ų |
| Heavy Atom Count | 9 |
| Formal Charge | 0 |
| Complexity | 101 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
ABOUT THIS PAGE
A D-Leucine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of D-Leucine, including repackagers and relabelers. The FDA regulates D-Leucine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. D-Leucine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of D-Leucine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A D-Leucine supplier is an individual or a company that provides D-Leucine active pharmaceutical ingredient (API) or D-Leucine finished formulations upon request. The D-Leucine suppliers may include D-Leucine API manufacturers, exporters, distributors and traders.
click here to find a list of D-Leucine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
D-Leucine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of D-Leucine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right D-Leucine GMP manufacturer or D-Leucine GMP API supplier for your needs.
A D-Leucine CoA (Certificate of Analysis) is a formal document that attests to D-Leucine's compliance with D-Leucine specifications and serves as a tool for batch-level quality control.
D-Leucine CoA mostly includes findings from lab analyses of a specific batch. For each D-Leucine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
D-Leucine may be tested according to a variety of international standards, such as European Pharmacopoeia (D-Leucine EP), D-Leucine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (D-Leucine USP).
LOOKING FOR A SUPPLIER?
